Clinical Case 4

[1]  P. Stjärne,et al.  Evaluation of different hydrocortisone treatment strategies in transsphenoidal pituitary surgery , 2019, Acta Neurochirurgica.

[2]  M. Buchfelder,et al.  Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management , 2019, Pituitary.

[3]  Y. Greenman,et al.  Dopamine Agonists for Pituitary Adenomas , 2018, Front. Endocrinol..

[4]  P. Delgado-López,et al.  Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options , 2018, Clinical and Translational Oncology.

[5]  M. Gadelha,et al.  Apoplexy in nonfunctioning pituitary adenomas , 2018, Pituitary.

[6]  J. Flickinger,et al.  Management of nonfunctioning pituitary tumors: radiotherapy , 2018, Pituitary.

[7]  J. Wass,et al.  Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas , 2018, Pituitary.

[8]  Y. Greenman,et al.  Management of NFAs: medical treatment , 2018, Pituitary.

[9]  Xiaobing Jiang,et al.  Outcomes of endoscopic and microscopic transsphenoidal surgery on non‐functioning pituitary adenomas: a systematic review and meta‐analysis , 2018, Journal of cellular and molecular medicine.

[10]  E. Laws,et al.  Management of non-functioning pituitary adenomas: surgery , 2018, Pituitary.

[11]  M. Mercado,et al.  Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects. , 2017, Endocrinologia, diabetes y nutricion.

[12]  James V. Byrne,et al.  Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers , 2017, The Journal of clinical endocrinology and metabolism.

[13]  Bin Yu,et al.  Clinical characteristics and risk factors for headache associated with non-functioning pituitary adenomas , 2017, Cephalalgia : an international journal of headache.

[14]  S. Corsello,et al.  Current best practice in the management of patients after pituitary surgery , 2017, Therapeutic advances in endocrinology and metabolism.

[15]  M. Murad,et al.  Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[16]  Claudia Scaringi,et al.  Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas. , 2016, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[17]  H. Dufour,et al.  Non-functioning pituitary adenoma: when and how to operate? What pathologic criteria for typing? , 2015, Annales d'endocrinologie.

[18]  G. Assié,et al.  Biological and radiological exploration and management of non-functioning pituitary adenoma. , 2015, Annales d'endocrinologie.

[19]  P. Chanson,et al.  Post-surgical management of non-functioning pituitary adenoma. , 2015, Annales d'endocrinologie.

[20]  P. Chanson,et al.  Management of clinically non-functioning pituitary adenoma. , 2015, Annales d'endocrinologie.

[21]  L. Kasuki,et al.  Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy , 2015, Clinical endocrinology.

[22]  Chiyuan Ma,et al.  Is Peri-Operative Steroid Replacement Therapy Necessary for the Pituitary Adenomas Treated with Surgery? A Systematic Review and Meta Analysis , 2015, PloS one.

[23]  N. Karavitaki,et al.  Efficacy and complications of pituitary irradiation. , 2015, Endocrinology and metabolism clinics of North America.

[24]  L. Naves,et al.  Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas , 2013, Pituitary.

[25]  M. Zatelli,et al.  Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion , 2013, Pituitary.

[26]  D. Yang,et al.  Radiotherapy for pituitary adenomas: long-term outcome and complications , 2011, Radiation oncology journal.

[27]  V. Montori,et al.  Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. , 2011, The Journal of clinical endocrinology and metabolism.

[28]  V. Montori,et al.  Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline , 2011, The Journal of clinical endocrinology and metabolism.

[29]  V. Montori,et al.  Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta‐analysis , 2010, Clinical endocrinology.

[30]  C. Marosi,et al.  O6‐methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas , 2009, Cancer.

[31]  Yi-cheng Lu,et al.  Clinical analysis of 103 elderly patients with pituitary adenomas: Transsphenoidal surgery and follow-up , 2008, Journal of Clinical Neuroscience.

[32]  O. Dekkers,et al.  The natural course of non-functioning pituitary macroadenomas. , 2007, European journal of endocrinology.

[33]  L. Cavallo,et al.  Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. , 2004, The Journal of clinical endocrinology and metabolism.

[34]  S. Melmed,et al.  Diagnosis and management of nonfunctioning pituitary tumors. , 1996, Annual review of medicine.